AI will continue to attract investment in near future in the healthcare industry
Many healthcare companies are expected to prioritise AI as their main investment target over the next two years.
Scotland Health Tech WP
Japan grants emergency regulatory approval for Shionogi’s Covid-19 drug
Health Canada grants expanded authorisation for Novavax’s Covid-19 vaccine
Chronic drug shortages signal difficult outlook for cardiovascular care
Inside the European mass shift to data-driven health solutions
Cloud robotics labs are accelerating drug discovery and development
Bayer’s CKD and type 2 diabetes therapy gets Health Canada approval
Pharma’s ESG goals need to underscore push for health equity
